Contact

Click here for a confidential contact or call:

1-212-350-2774

Archive

Page 51 of 51

Deducting the Cost of Fraud -- The Widespread Treatment of Government Settlements as a Mere Business Expense

Posted  10/17/12
By Gordon Schnell With its $9 billion take, it has been a record year for the government in terms of its recoveries under the False Claims Act.  See Banner Year for Whistleblowers . . . .  There was the $3 billion settlement with GlaxoSmithKline over its marketing misdeeds with Paxil and Wellbutrin and its failure to report safety data for Avandia.  See Big Pharma Strikes Again . . . .   There was the $1.5...

Tagged in: Healthcare Fraud,

Read More

The Fraud Behind the Fraud of Off-Label Drug Marketing

Posted  10/5/12
By Gordon Schnell It has been one of the most common means for drug companies to get around what can be the very rigorous and time-consuming process of securing FDA approval for selling drugs.  That is, taking drugs that the FDA has approved as safe and effective for one particular use and marketing them to the medical community and the public for an entirely different set of uses.  This so-called off-label...

Tagged in: Healthcare Fraud, Off-Label and Unapproved Use, Pharma Fraud,

Read More

What is Going On With Big Pharma?

Posted  09/13/12
By Gordon Schnell With GlaxoSmithKline’s recent blockbuster $3 billion settlement with the Department of Justice -- the largest health care fraud penalty on record -- you have to wonder what is going on in the world of Big Pharma these days.  This is an industry that constantly complains of being misunderstood, underappreciated and unfairly maligned.  And there is some legitimacy to their lament.  Afterall,...

Tagged in: Healthcare Fraud,

Read More

Johnson & Johnson’s Risperdal Woes Roll On

Posted  09/13/12
By Jason Enzler The hits keep coming for Johnson & Johnson.  On August 30, several state attorneys general announced that they have agreed to a $181 million settlement with Janssen Pharmaceuticals, a J & J subsidiary, regarding charges that the company was illegally promoting its antipsychotic drugs Risperdal and Invega.  Click here for a press release from New York.  The settlement, involving 36 states and the...

Tagged in: Healthcare Fraud,

Read More

The Government's New Public-Private Partnership in Tackling Healthcare Fraud – Seeking Prevention Over Punishment

Posted  08/16/12
By Marlene Koury The government has done a good job of late in recovering billions of dollars of fines from a host of companies big and small for committing various acts of healthcare fraud.  The recoveries so far for this year alone have been record-setting, on their way to crossing the $10 billion mark.  And this number is sure to grow even higher as the Obama Administration continues to ramp up its efforts to...

Tagged in: Healthcare Fraud,

Read More

Partnering With Former Fraudsters and Conflicted Parties to Root Out Health Care Fraud -- Is the Government Letting the Fox Guard the Hen House?

Posted  08/1/12
By Marlene Koury The government announced last week that it would be partnering with Amerigroup in its new public-private partnership to prevent health care fraud.  If “Amerigroup” and “fraud” in the same sentence sound all too familiar, it is not because of the company's track record in fighting fraud.  Rather, it is likely because Amerigroup paid $225 million in 2008 to resolve claims that it defrauded...

Tagged in: Healthcare Fraud,

Read More

Here We Go Again -- Johnson & Johnson to Pay Upwards of $2.2 Billion to Settle Civil and Criminal Charges

Posted  07/31/12
By Jason Enzler Only a few weeks after GlaxoSmithKline's blockbuster $3 billion settlement over its healthcare fraud misdeeds relating to Paxil, Wellbutrin and Avandia, Johnson & Johnson is joining the party with a multi-billion dollar settlement of its own.   Though it has yet to be finalized, the Wall Street Journal reported that Johnson & Johnson and the DOJ have reached an agreement requiring the company to...

Tagged in: Healthcare Fraud,

Read More

FDAGate -- The Latest Lapse in Government Enforcement

Posted  07/20/12
By Gordon Schnell In what quickly has become the most recent "gate" scandal in Washington, the evidence continues to mount that the FDA acted to stifle whistleblowers within its own ranks.  It all began several years ago when a half-dozen FDA scientists and doctors objected to certain imaging devices for mammograms and colonoscopies because of the high levels of radiation they believed the equipment emitted.  The...

Tagged in: FDA Fraud,

Read More

Big Pharma Strikes Again – Glaxo Settles Largest Healthcare Fraud Case in History

Posted  07/13/12
By Jason Enzler Earlier this month, GlaxoSmithKline entered into the largest settlement in healthcare fraud history -- a whopping $3 billion -- to settle a broad range of criminal and civil charges involving the company’s drugs and marketing practices.  Glaxo’s settlement easily surpasses the previous record for healthcare fraud, Pfizer’s $2.3 billion payout in 2009 to settle criminal and civil charges for...

Tagged in: Healthcare Fraud,

Read More

Low Scores for Government Efforts to Clean Up Medicare/Medicaid Fraud

Posted  06/25/12
By Gordon Schnell The Government Accountability Office (GAO), the nonpartisan investigative arm of Congress, just issued a relatively unflattering report on the government's internal efforts to clean up Medicare and Medicaid fraud.  According to the report, the government makes more than $60 billion in improper Medicare and Medicaid payments every year because of fraud, waste and abuse of the system.  This comes...

Tagged in: Anti-Kickback and Stark,

Read More
1 … 48 49 50 51

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: